N-Acetylgalactosamine-6-Sulfatase
CAT:
804-HY-E70188-02
Size:
100 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

N-Acetylgalactosamine-6-Sulfatase
- UNSPSC Description: N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential general biomarker for multiple malignancies (such as lung cancer, breast cancer, head and neck cancer, etc.). N-Acetylgalactosamine-6-Sulfatase deficiency causes mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. N-Acetylgalactosamine-6-Sulfatase can be used in MPS IVA as well as cancer research[1][2].
- Target Antigen: Biochemical Assay Reagents
- Type: Enzyme
- Related Pathways: Others
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/n-acetylgalactosamine-6-sulfatase.html
- Solubility: 10 mM in DMSO
- Smiles: [N-Acetylgalactosamine-6-Sulfatase]
- References & Citations: [1]Ho ML, et al. N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies. Anticancer Res. 2019 Nov;39(11):6317-6324. |[2]Laradi S, et al. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients. Mol Genet Metab. 2006 Mar;87(3):213-8.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported